Dabrafenib and trametinib – March 2024

Dabrafenib and Trametinib: Dabrafenib: Capsule 50 mg (as mesilate), Capsule 75 mg (as mesilate), Tablet (dispersible) 10 mg; Tafinlar®; Trametinib: Tablet 500 micrograms, Tablet 2 mg, Powder for oral solution 5 micrograms per mL (as dimethylsulfoxide), 97 mL; Mekinist® – March 2024 – December 2024